Evidence map›Paper›PMID 29642007›Full record

ArticleCell reports2018

How Biophysical Forces Regulate Human B Cell Lymphomas.

F Apoorva, Alexander M Loiben, Shivem B Shah, Alberto Purwada, Lorena Fontan, Rebecca Goldstein, Brian J Kirby, Ari M Melnick, Benjamin D Cosgrove, Ankur Singh

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Goodbye flat lymphoma biology.FEBS letters · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Intestinal organ chips for disease modelling and personalized medicine.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

F ApoorvaSibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY 14853, USA.
Alexander M LoibenNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA.
Shivem B ShahNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA.
Alberto PurwadaNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA.
Lorena FontanDivision of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA.
Rebecca GoldsteinDivision of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA.
Brian J KirbySibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY 14853, USA; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA.
Ari M MelnickDivision of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA.
Benjamin D CosgroveNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA.
Ankur SinghSibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY 14853, USA; Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA; Englander Institute for Precision Medicine, Weill Cornell Medical College, New York, NY 10021, USA. Electronic address: as2833@cornell.edu.
Cornell University · US

Funding

Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signalingR01AI132738 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI SINGH, ANKUR · 2018 to 2022
$1.9M
MALT1 Targeted Therapy for B-Cell LymphomaR01CA187492 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MELNICK, ARI M. · 2014 to 2017
$1.4M
LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and GenomicsR33CA212968 · NCI · CORNELL UNIVERSITY · PI SINGH, ANKUR · 2017 to 2019
$1.1M
Supplement to: EX VIVO REJUVENATION AND EXPANSION OF MUSCLE STEM CELLS FROM AGED MICER00AG042491 · NIA · CORNELL UNIVERSITY · PI COSGROVE, BENJAMIN DAVID · 2014 to 2016
$790k
NCI NIH HHS R01 CA187492NCI NIH HHS R33 CA212968NIAID NIH HHS R01 AI132738NIA NIH HHS R00 AG042491
6 · The paper itself

Abstract

The role of microenvironment-mediated biophysical forces in human lymphomas remains elusive. Diffuse large B cell lymphomas (DLBCLs) are heterogeneous tumors, which originate from highly proliferative germinal center B cells. These tumors, their associated neo-vessels, and lymphatics presumably expose cells to particular fluid flow and survival signals. Here, we show that fluid flow enhances proliferation and modulates response of DLBCLs to specific therapeutic agents. Fluid flow upregulates surface expression of B cell receptors (BCRs) and integrin receptors in subsets of ABC-DLBCLs with either CD79A/B mutations or WT BCRs, similar to what is observed with xenografted human tumors in mice. Fluid flow differentially upregulates signaling targets, such as SYK and p70S6K, in ABC-DLBCLs. By selective knockdown of CD79B and inhibition of signaling targets, we provide mechanistic insights into how fluid flow mechanomodulates BCRs and integrins in ABC-DLBCLs. These findings redefine microenvironment factors that regulate lymphoma-drug interactions and will be critical for testing targeted therapies.

Indexed as

AnimalsApoptosisCD79 AntigensCell Line, TumorCytokinesDoxorubicinHumansIntegrinsLymphoma, Large B-Cell, DiffuseMiceMice, Inbred NODMicrofluidicsReceptors, Antigen, B-CellRNA InterferenceRNA, Small InterferingShear StrengthCD79 AntigensCytokinesDoxorubicinIntegrinslyn protein-tyrosine kinaseReceptors, Antigen, B-CellRNA, Small Interferingsrc-Family KinasesB cell receptorchemotherapyfluidintegrinlymphaticslymph nodemechanomodulationmutationshear stresssignaling

Identifiers

PMID29642007
PMCPMC5965297
OpenAlexW2797647983

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.